Natural Antioxidant—Great for Liver Health

Milk Thistle References

  1. Cultivation of milk thistle (Silybum marianum L. Gaertn.), a medicinal weed. Karkanis, Anestis, Bilalis, Dimitrios and Efthimiadou, Aspasia. [ed.] D.T. Ray, M.J. Pascual-Villalobos and M.N. Belgacem. 1, Tucson; Murcia; St. Martin d'Hères: Elsevier B.V., July 2011, Industrial Crops and Products, Vol. 34, pp. 825-830. DOI: 10.1016/j.indcrop.2011.03.027; ISSN: 0926-6690.
  2. Brenneman, William L. 50 Wild Plants Everyone Should Know. Bloomington: AuthorHouse, 2010. ISBN-13: 978-1-4520-4637-2.
  3. Khan, Ikhlas A. and Abourashed, Ehab A. Leung's Encyclopedia of Common Natural Ingredients: Used in Food, Drugs and Cosmetics. 3. Hoboken: John Wiley & Sons, Inc., 2010. ISBN: 978-0-471-46743-4.
  4. 4. Stargrove, Mitchell Bebel, Treasure, Jonathan and McKee, Dwight L. Herb, Nutrient, and Drug Interactions. St. Louis: Elsevier Health Sciences, 2008. ISBN-13: 978-0-323-02964-3.
  5. Quattrocchi, Umberto. CRC World Dictionary of Medicinal and Poisonous Plants: Common Names, Scientific Names, Eponyms, Synonyms, and Etymology. Boca Raton: CRC Press: Taylor & Francis Group, 2012. ISBN-13: 978-1-4822-5064-0.
  6. Bailey, Liberty Hyde and Miller, Wilhelm. Cyclopedia of American Horticulture, Comprising Suggestions for Cultivation of Horticultural Plants, Descriptions of the Species of Fruits, Vegetables, Flowers and Ornamental Plants Sold in the United States and Canada, Together with Geographical. New York: The Macmillan Company, 1904. Vol. 4.
  7. Parsons, W.T. and Cuthbertson, E.G. Noxious Weeds of Australia. 2nd. Collingwood: Csiro Publishing, 2001. ISBN: 0-643-06514-8.
  8. Philp, Robert Kemp. The Family Save-All, a System of Secondary Cookery. 2nd. London: W. Kent & Co., 1861.
  9. Memorial Sloan Kettering Cancer Center. Milk Thistle. Integrative Medicine: About Herbs, Botanicals & Other Products. [Online] September 3, 2014. [Cited: February 20, 2017.]
  10. Burbank, Luther. How Plants Are Trained to Work for Man: Gardening. New York: P.F. Collier & Son Company, 1921. Vol. V.
  11. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. Ferenci, P., et al., et al. [ed.] Dame Sheila Sherlock. 1, London: Elsevier Inc.: European Association for the Study of the Liver, July 1989, Journal of Hepatology, Vol. 9, pp. 105-113. DOI: 10.1016/0168-8278(89)90083-4; ISSN: 0168-8278.
  12. Silymarin, the Antioxidant Component of Silybum marianum, Prevents Sepsis-Induced Acute Lung and Brain Injury. Toklu, Hale Z., et al., et al. [ed.] David W. McFadden and Wiley W. Souba. 2, Burlington; Columbus: Elsevier B.V., April 2008, Journal of Surgical Research, Vol. 145, pp. 214-222. DOI: 10.1016/j.jss.2007.03.072; ISSN: 0022-4804.
  13. An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin. Saller, Reinhard, et al., et al. [ed.] Harald Walach. 1, Poznan: S. Karger AG, Basel, February 2008, Complementary Medicine Research, Vol. 15, pp. 9-20. DOI: 10.1159/000113648; ISSN: 2504-2092.
  14. The effects of silymarin on experimental phalloidine poisoning. Desplaces, A., et al., et al. 1, s.l.: Georg Thieme Verlag KG, January 1975, Arzneimittelforschung, Vol. 25, pp. 89-96. ISSN: 0004-4172.
  15. Wynn, Susan G. and Fougère, Barbara. Veterinary herbal medicine. St. Louis: Mosby, Inc.: Elsevier Health Sciences, 2007. ISBN-13: 978-0-323-02998-8.
  16. Characterization of chitosan-nanoclay bionanocomposite active films containing milk thistle extract. Ghelejlu, Sara Beigzadeh, Esmaiili, Mohsen and Almasi, Hadi. [ed.] A. Dong and J.F. Kennedy. Greeley; Bromsgrove: Elsevier B.V., May 2016, International Journal of Biological Macromolecules, Vol. 86, pp. 613-621. DOI: 10.1016/j.ijbiomac.2016.02.012; ISSN: 0141-8130.
  17. Chitin and chitosan: Properties and applications. Rinaudo, Marguerite. [ed.] G.C. Berry and K. Matyjaszewski. 7, Pittsburgh: Elsevier Ltd., July 2006, Progress in Polymer Science, Vol. 31, pp. 603-632. DOI: 10.1016/j.progpolymsci.2006.06.001; ISSN: 0079-6700.
  18. Silybum marianum extract as a natural source inhibitor for 304 stainless steel corrosion in 1.0 M HCl. Soltani, N., et al., et al. [ed.] Bok Ryul Yoo. 5, Seoul: Elsevier B.V., September 25, 2014, Journal of Industrial and Engineering Chemistry, Vol. 20, pp. 3217-3227. DOI: 10.1016/j.jiec.2013.12.002; ISSN: 1226-086X.
  19. Biodiesel production from non-edible Silybum marianum oil using heterogeneous solid base catalyst under ultrasonication. Takase, Mohammed, et al., et al. [ed.] Timothy J. Mason. 5, Coventry: Elsevier B.V., September 2014, Ultrasonics Sonochemistry, Vol. 21, pp. 1752-1762. DOI: 10.1016/j.ultsonch.2014.04.003; ISSN: 1350-4177.
  20. A Review of Plants Used in the Treatment of Liver Disease: Part 1. Luper, Scott. [ed.] Timothy Birdsall. 6, Napa: Thorne Research, Inc., 1998, Alternative Medicine Review, Vol. 3, pp. 410-421. ISSN: 1089-5159.
  21. Phytotherapeutic properties of milk thistle seeds: An overview. Bhattacharya, Sanjib. [ed.] Eric Jones. Columbia: Elsevier, July 26, 2011, Journal of Advanced Pharmacy Education & Research, Vol. 1, pp. 69-79. ISSN: 2249-3379.
  22. Silibinin: A Thorny Therapeutic for EGF-R Expressing Tumors?. Hannay, Jonathan A.F. and Yu, Dihua. [ed.] Wafik S. El-Deiry. 5, Philadelphia: Landes Bioscience, September/October 2003, Cancer Biology & Therapy, Vol. 2, pp. 532-533. ISSN: 1538-4047.
  23. Ethnopharmacological survey of medicinal herbs in Israel, the Golan Heights and the West Bank region. Said, O., et al., et al. [ed.] Laurent Rivier and Jan G. Bruhn. 3, Lausanne: Elsevier Ireland Ltd., December 2002, Journal of Ethnopharmacology, Vol. 83, pp. 251-265. DOI: 10.1016/S0378-8741(02)00253-2; ISSN: 0378-8741.
  24. Traditional Chinese medicine and related active compounds: A review of their role on hepatitis B virus infection. Qi, Fanghua, et al., et al. [ed.] Kazuhisa Sekimizu. 6, Tokyo: International Advancement Center for Medicine & Health Research Co., Ltd., July 2013, Drug Discoveries & Therapeutics, Vol. 7, pp. 212-224. DOI: 10.5582/ddt.2013.v7.6.212; ISSN: 1881-7831.
  25. Zhou, Jiaju, Xie, Guirong and Yan, Xinjian. Encyclopedia of Traditional Chinese Medicines: Molecular Structures, Pharmacological Activities, Natural Sources and Applications. Berlin: Springer-Verlag, 2011. Vols. 5: Isolated Compounds T-Z. ISBN: 978-3-642-16740-9.
  26. Fight Psoriasis Naturally Through Ayurveda. Vibhooti, Papola, et al., et al. [ed.] Akash Dhokne. 7, North Shore City: Indo-American Pharmaceutical Society, 2016, Indo American Journal of Pharmaceutical Research, Vol. 6, pp. 6280-6290. ISSN: 2231-6876.
  27. Tobyn, Graeme, Denham, Alison and Whitelegg, Margaret. The Western Herbal Tradition. [ed.] Sheila Kingsbury. Seattle: Elsevier Ltd., 2011. ISBN: 978-0-443-10344-5.
  28. Flavonoids of the Flowers of Silybum marianum. Ahmed, Ahmed A., Mabry, Tom J. and Matlin, Stephen A. 6, s.l.: Elsevier Ltd., 1989, Phytochemistry, Vol. 28, pp. 1751-1753. ISSN: 0031-9422.
  29. Phenolic profile and in vitro antioxidant power of different milk thistle [Silybum marianum (L.) Gaertn.] cultivars. Lucini, Luigi, et al., et al. [ed.] M.J. Pascual-Villalobos, et al., et al. Murcia; St. Martin d'Hères; Fargo; Sao Paulo: Elsevier B.V., May 2016, Industrial Crops and Products, Vol. 83, pp. 11-16. DOI: 10.1016/j.indcrop.2015.12.023; ISSN: 0926-6690.
  30. Elemental analysis of some medicinal plants used in traditional medicine by atomic absorption spectrophotometer (AAS). Zafar, Muhammad, et al., et al. [ed.] Akah Peter Achunike. 19, Nsukka: Academic Journals, October 2010, Journal of Medicinal Plants Research, Vol. 4, pp. 1987-1990. DOI: 10.5897/JMPR10.081; ISSN: 1996-0875.
  31. Properties of the seed oil of a dwarf cultivar of the pharmaceutical silymarin producing plant Silybum marianum (L.) Gaertn. developed in India. Bahi, J.R., et al., et al. [ed.] Sunita Garg. 2, New Delhi: National Institute of Science Communication And Information Resources, June 2015, Indian Journal of Natural Products and Resources, Vol. 6, pp. 127-133. ISSN: 0976-0512.
  32. Chymotrypsin Inhibitory Triterpenoids from Silybum marianum. Ahmed, Ejaz, et al., et al. [ed.] Yoshiji Takemoto. 1, Kyoto: International Academic Publishing Co., Ltd.: Phamnaceutical Society of Japan, January 2006, Chemical and Pharmaceutical Bulletin, Vol. 54, pp. 103-106. ISSN: 0009-2363.
  33. Detailed studies on some lipids of Silybum marianum(L.) seed oil. El-Mallah, M. Hassan, Safinaz, M. El-Shami and Hassanein, Minar M. [ed.] José María García Martos. 4, Seville: Consejo Superior de Investigaciones Científicas (CSIC), 2003, Grasas y Aceites: International Journal of Fats and Oils, Vol. 54, pp. 397-402. DOI: 10.3989/gya.2003.v54.i4.227; ISSN: 0017-3495.
  34. St. John, Tina M. Chronic Hepatitis. [ed.] David Rakel. Integrative Medicine. 3rd. Philadelphia: Saunders: Elsevier Inc., 2012, 19, pp. 171-186.e4. ISBN: 978-1-4377-1793-8.
  35. Linkner, Edward (Lev) and Humphreys, Corene. Insulin Resistance and the Metabolic Syndrome. [ed.] David Rakel. Integrative Medicine. 3rd. Philadelphia: Saunders: Elsevier Inc., 2012, 31, pp. 284-296.e4. ISBN: 978-1-4377-1793-8.
  36. Figurski, Ann C. Cholelithiasis. [ed.] David Rakel. Integrative Medicine. 3rd. Philadelphia: Saunders: Elsevier Inc., 2012, 43, pp. 415-421.e1. ISBN: 978-1-4377-1793-8.
  37. Clinical Applications of Silybum marianum in Oncology. Greenlee, Heather, et al., et al. [ed.] Keith I. Block. 2, Chicago: Sage Publications, June 1, 2007, Integrative Cancer Therapies, Vol. 6, pp. 158-165. DOI: 10.1177/1534735407301727; ISSN: 1534-7354.
  38. Spontaneous regression of advanced hepatocellular carcinoma: a case report. Hsu, Chuan-Yuan, et al., et al. [ed.] Richard Smith. 6251, London: BioMed Central Ltd., August 7, 2009, Cases Journal, Vol. 2, pp. 1-5. DOI: 10.4076/1757-1626-2-6251; ISSN: 1757-1626.
  39. Galland, Leo. Inflammatory Bowel Disease. [ed.] David Rakel. Integrative Medicine. 3rd. Philadelphia: Saunders: Elsevier Inc., 2012, 49, pp. 464-474.e5. ISBN: 978-1-4377-1793-8.
  40. Gladstar, Rosemary. Rosemary Gladstar's Herbal Recipes for Vibrant Health: 175 Teas, Tonics, Oils, Salves, Tinctures, and Other Natural Remedies for the Entire Family. Adams: Storey Publishing, 2008. ISBN: 978-1-60342-078-5.
  41. Swallowtail Garden Seeds. Milk Thistle Seeds. Swallowtil Garden Seeds. [Online] 1998-2017. [Cited: February 26, 2017.]
  42. On the pollen harvest by the honey bee (Apis mellifera L.) near Tucson, Arizona (1976-1981). O'Neal, Robert J. and Waller, Gordon D. 2, Tucson: University of Arizona; Boyce Thompson Arboretum, 1984, Desert Plants Journal, Vol. 6, pp. 81-109. DOI: 10150/552253; ISSN: 0734-3434.
  43. A model for predicting geographic origin of honey from the same floral source. Karabournioti, S., Thrasyvoulou, A. and Eleftheriou, E.P. 3, East Sussex: Taylor & Francis: International Bee Research Association, June 27, 2006, Journal of Apicultural Research, Vol. 45, pp. 117-124. ISSN: 1360-2004.
  44. Cheek, Linda S. Herb Survival Manual for North America. 2013.
  45. Ehrlich, Steven D. Milk thistle. University of Maryland Medical Center Medical Reference Guide: Complementary and Alternative Medicine Guide. [Online] May 26, 2014. [Cited: February 20, 2017.]
  46. Silychristin, a Flavonolignan Derived From the Milk Thistle, Is a Potent Inhibitor of the Thyroid Hormone Transporter MCT8. Johannes, Jörg, et al., et al. [ed.] Andrea C. Gore and Stephen R. Hammes. 4, Austin; Rochester: The Endocrine Society, February 24, 2016, Endocrinology, Vol. 157, pp. 1694-1701. DOI: 10.1210/en.2015-1933; ISSN: 0013-7227.
  47. Brinker, Francis. Herbal Contraindications and Drug Interactions plus Herbal Adjuncts with Medicines. 4th. Sandy: Eclectic Medical Publications, 2012 update. ISBN-13: 978-1-888483-14-7.
  48. In Vitro Antimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin. de Oliveira, Dayanne Rakelly, et al., et al. [ed.] Glen Jickling. Article ID 292797, Davis: Hindawi Publishing Corporation, February 15, 2015, BioMed Research International, Vol. 2015, pp. 1-7. DOI: 10.1155/2015/292797; ISSN: 1110-7243.
  49. Clinical efficacy, safety and tolerability of BIO-C® (micronized Silymarin) as a galactagogue. Pierro, Francesco Di, et al., et al. [ed.] Maurizio Vanelli. 3, Parma: Society of Medicine and Natural Sciences of Parma, December 2008, Acta BioMedica, Vol. 79, pp. 205-210. PMID: 19260380. ISSN: 0392-4203.
  50. Silibinin modulates the NF-κb pathway and pro-inflammatory cytokine production by mononuclear cells from preeclamptic women. Giorgi, Vanessa S. Innocenti, et al., et al. [ed.] Sarah A. Robertson, Shigeru Saito and D. Ware Branch. 1-2, Adelaide; Toyama; Salt Lake City: Elsevier Ireland Ltd., September 2012, Journal of Reproductive Immunology, Vol. 95, pp. 67-72. DOI: 10.1016/j.jri.2012.06.004; ISSN: 0165-0378.
  51. The impact of Silymarin on improvement of platelet abnormalities in patients with severe preeclampsia. Baghbahadorani, Fahimeh Kaveh and Miraj, Sepideh. [ed.] Mehrdad Jalalian and Parichehr Hanachi. 5, Kuala Lumpur; Tehran: Mehr Publishing, May 2016, Electronic Physician Journal, Vol. 8, pp. 2436-2442. DOI: 10.19082/2436; ISSN: 2008-5842.
  52. Solid-State Fermentation of Silybum marianum L. Seeds Used as Additive to Increase the Nutritional Value of Wheat Bread. Juodeikiene, Grazina, et al., et al. [ed.] Vladimir Mrša. 4, Zagreb: Faculty of Food Technology and Biotechnology, University of Zagreb, March 29, 2013, Food Technology and Biotechnology, Vol. 51, pp. 528-538. ISSN: 1330-9862.
  53. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update. Melnik, Bodo C. [ed.] Jeffrey M. Weinberg. 8, New York City: Dove Press Ltd, July 15, 2015, Clinical, Cosmetic and Investigational Dermatology, Vol. 2015, pp. 371-388. DOI: 10.2147/CCID.S69135; ISSN: 1178-7015.
  54. Protective effect of silymarin in antigen challenge- and histamine-induced bronchoconstriction in in vivo guinea-pigs. Breschi, M. Cristina, et al., et al. [ed.] F.P. Nijkamp. 1-2, Utrecht: Elsevier B.V., February 15, 2002, European Journal of Pharmacology, Vol. 437, pp. 91-95. DOI: 10.1016/S0014-2999(02)01265-7; ISSN: 0014-2999.
  55. Silymarin potentiates the anti-inflammatory effects of Celecoxib on chemically induced osteoarthritis in rats. Ashkavand, Z., et al., et al. [ed.] Hildebert Wagner. 13, München: Elsevier GmbH: Urban and Fischer, October 15, 2012, Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, Vol. 19, pp. 1200-1205. DOI: 10.1016/j.phymed.2012.07.008; ISSN: 0944-7113.
  56. Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis. Mady, Fatma M., et al., et al. [ed.] Frank Boeckler and Jim Janetka. Tuebingen; St. Louis: Dove Press Ltd, March 10, 2016, Drug Design, Development and Therapy , Vol. 10, pp. 1101-1110. DOI: 10.2147/DDDT.S103423; ISSN: 1177-8881.
  57. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Evren, Ebru and Yurtcu, Erkan. [ed.] J. Mateju. 4, Prague: Springer International Publishing AGl Institute of Microbiology, Academy of Sciences of the Czech Republic and Czechoslavak Society for Microbiology, July 2015, Folia Microbiologica, Vol. 60, pp. 351-356. DOI: 10.1007/s12223-015-0399-6; ISSN: 0015-5632.
  58. The natural flavonoid silybin improves the response to Photodynamic Therapy of bladder cancer cells. Gándara, L., et al., et al. [ed.] László Mátyus and Robert Carpentier. Debrecen; Trois-Rivières: Elsevier B.V., April 5, 2014, Journal of Photochemistry and Photobiology B: Biology, Vol. 135, pp. 55-64. DOI: 10.1016/j.jphotobiol.2014.03.006; ISSN: 1011-1344.
  59. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment. Lu, Ping, et al., et al. [ed.] Joe P. Huston. 2, Düsseldorf: Elsevier B.V., March 5, 2010, Behavioural Brain Research, Vol. 207, pp. 387-393. DOI: 10.1016/j.bbr.2009.10.024; ISSN: 0166-4328.
  60. Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice. Ho, Bing-Ying, et al., et al. [ed.] Lee-Yan Sheen. 4, Taipei: Elsevier, B.V., October-December 2012, Journal of Traditional and Complementary Medicine, Vol. 2, pp. 301-311. DOI: 10.1016/S2225-4110(16)30116-X; ISSN: 2225-4110.
  61. The effect of herbal medicine Silybum marianum (L.) Gaertn. seed extract on galactose induced cataract formation in rat. Huseini, Hasan Fallah, et al., et al. [ed.] Sh. Akhoundzadeh. 12, Tehran: Iranian Academic Center of Education, Culture and Research, December 2004, Journal of Medicinal Plants, Vol. 4, pp. 58-62. ISSN: 1684-0240.
  62. Synergistic Antibacterial Effect between Silibinin and Antibiotics in Oral Bacteria. Lee, Young-Soo, Jang, Kyeung-Ae and Cha, Jeong-Dan. [ed.] Ikhlas A. Khan. Article ID 618081, University: Hindawi Publishing Corporation, July 14, 2012, Journal of Biomedicine and Biotechnology, Vol. 2012, pp. 1-7. DOI: 10.1155/2012/618081; ISSN: 1110-7243.
  63. Antiviral activity of silymarin against chikungunya virus. Lani, Rafidah, et al., et al. [ed.] Philip Campbell. Article number: 11421, London: Macmillan Publishers Limited, part of Springer Nature, June 16, 2015, Scientific Reports, Vol. 5. DOI: 10.1038/srep11421; ISSN: 2045-2322.
  64. Topical application of silymarin reduces chemical-induced irritant contact dermatitis in BALB/c mice. Han, Mi Hwa, et al., et al. [ed.] J.E. Talmadge. 13, Omaha: Elsevier B.V., December 15, 2007, International Immunopharmacology, Vol. 7, pp. 1651-1658. DOI: 10.1016/j.intimp.2007.08.019; ISSN: 1567-5769.
  65. Potential antidepressant-like activity of silymarin in the acute restraint stress in mice: Modulation of corticosterone and oxidative stress response in cerebral cortex and hippocampus. Thakare, Vishnu N., Dhakane, Valmik D. and Patel, Bhoomika M. [ed.] Władysław Lason. 5, Kraków: Elsevier B.V., October 2016, Pharmacological Reports, Vol. 68, pp. 1020-1027. DOI: 10.1016/j.pharep.2016.06.002; ISSN: 1734-1140.
  66. Long-term (23 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. Velussi, Mario, et al., et al. [ed.] Gustav Paumgartner. 4, Munich: Elsevier Inc.: European Association for the Study of the Liver, April 1997, Journal of Hepatology, Vol. 26, pp. 871-879. DOI: 10.1016/S0168-8278(97)80255-3; ISSN: 0168-8278.
  67. Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus. Soto, C., et al., et al. [ed.] Hildebert Wagner. 14, München: Elsevier GmbH: Urban and Fischer, December 1, 2010, Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, Vol. 17, pp. 1090-1094. DOI: 10.1016/j.phymed.2010.04.011; ISSN: 0944-7113.
  68. Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial. Fallahzadeh, Mohammad Kazem, et al., et al. [ed.] Andrew S. Levey. 6, Philadelphia: Elsevier B.V., December 2012, American Journal of Kidney Diseases, Vol. 60, pp. 896-903. DOI: 10.1053/j.ajkd.2012.06.005; ISSN: 0272-6386.
  69. Chronic treatment of silymarin improves hyperalgesia and motor nerve conduction velocity in diabetic neuropathic rat. Baluchnejadmojarad, Tourandokht, Roghani, Mehrdad and Khastehkhodaie, Zeynab. [ed.] Elizabeth M. Williamson, et al., et al. 8, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., August 2010, Phytotherapy Research, Vol. 24, pp. 1120-1125. DOI: 10.1002/ptr.3078; eISSN: 1099-1573.
  70. Silybin reduces obliterated retinal capillaries in experimental diabetic retinopathy in rats. Zhang, Hong-Tao, et al., et al. [ed.] F.P. Nijkamp and W.H. Gispen. Utrecht: Elsevier B.V., October 5, 2014, European Journal of Pharmacology, Vol. 740, pp. 233-239. DOI: 10.1016/j.ejphar.2014.07.033; ISSN: 0014-2999.
  71. Anti-aging potential of a cream containing milk thistle extract: Formulation and in vivo evaluation. Rasul, A. and Akhtar, N. 6, 2012, African Journal of Biotechnology, Vol. 11.
  72. Anti-herpes virus activity of silibinin, the primary active component of Silybum marianum. Cardile, Anthony P. and Mbuy, Gustave K.N. [ed.] Barbara Pendry. 4, Exeter: Elsevier GmbH, December 2013, Journal of Herbal Medicine, Vol. 3, pp. 132-136. DOI: 10.1016/j.hermed.2013.07.002; ISSN: 2210-8033.
  73. Inhibition Studies of Bovine Xanthine Oxidase by Luteolin, Silibinin, Quercetin, and Curcumin. Pauff, James M. and Hille, Russ. [ed.] A. Douglas Kinghorn. 4, Columbus: American Chemical Society and American Society of Pharmacognosy, April 1, 2009, Journal of Natural Products, Vol. 72, pp. 725-731. DOI: 10.1021/np8007123; ISSN: 0163-3864.
  74. Protective Effect of Silymarin on Noise-Induced Hearing Loss in Guinea Pigs. Mohammadkhani, Ghassem, et al., et al. [ed.] Seyed Amir Mohsen Ziaee. 11, Tehran: Kowsar Publishing Corporation, November 2013, Iranian Red Crescent Medical Journal, Vol. 15, p. e8890. DOI: 10.5812/ircmj.8890; ISSN: 2074-1804.
  75. Silymarin and its constituents in cardiac preconditioning. Zholobenko, A. and Modriansky, M. [ed.] G. Appendino. Novara: Elsevier Science B.V., September 2014, Fitoterapia, Vol. 97, pp. 122-132. DOI: 10.1016/j.fitote.2014.05.016; ISSN: 0367-326X.
  76. Effects of Silybum marianum Extract on High-Fat Diet Induced Metabolic Disorders in Rats. Sayin, Fatma Kubra, et al., et al. [ed.] Henryk Zieliński. 1, Olsztyn: Walter de Gruyter GmbH, March 2016, Polish Journal of Food and Nutrition Sciences, Vol. 66, pp. 43-50. DOI: 10.1515/pjfns-2015-0014; eISSN: 2083-6007.
  77. Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient. Payer, B.A., et al., et al. [ed.] Bill Carman and Christine Ginocchio. 2, Glasgow; Lake Success: Elsevier B.V., October 2010, Journal of Clinical Virology, Vol. 49, pp. 131-133. DOI: 10.1016/j.jcv.2010.07.006; ISSN: 1386-6532.
  78. Immunostimulatory effect of Silybum Marianum (milk thistle) extract. Wilasrusmee, Chumpon, et al., et al. [ed.] George B. Stefano. 11, Old Westbury: International Scientific Information, Inc., November 21, 2002, Medical Science Monitor, Vol. 8, pp. 439-443. ID: 4847. eISSN: 1643-3750.
  79. A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study. Madisch, A., et al., et al. 7, s.l.: Georg Thieme Verlag KG, July 2001, German Journal of Gastroenterology, Vol. 39, pp. 511-517. DOI: 10.1055/s-2001-16142; ISSN: 0044-2771.
  80. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Madisch, A., et al., et al. [ed.] Roy E. Pounder and Walter L. Peterson. 3, London; Dallas: John Wiley & Sons Ltd, February 2004, Alimentary Pharmacology and Therapeutics, Vol. 19, pp. 271-279. DOI: 10.1111/j.1365-2036.2004.01859.x; eISSN: 1365-2036.
  81. The efficacy of Silybum marianum (L.) Gaertn. (Silymarin) in the treatment of physiological neonatal jaundice ( a randomized, double-blind, placebo-controlled, clinical trial). Kassem, Lamyaa M., Abdelrahim, Mohamed E.A. and Naguib, Hassan F. [ed.] Aida El-Azzouny. 2, Dokki-Cairo: Wolters Kluwer - Medknow, August 27, 2012, Egyptian Pharmaceutical Journal, Vol. 11, pp. 144-149. ISSN: 1687-4315.
  82. Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Ramakrishnan, Gopalakrishnan, et al., et al. [ed.] James A. Bond. 2, Durham: Elsevier Ireland Ltd., June 10, 2006, Chemico-Biological Interactions, Vol. 161, pp. 104-114. DOI: 10.1016/j.cbi.2006.03.007; ISSN: 0009-2797.
  83. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells. Cufí, Sílvia, et al., et al. [ed.] A. Wallace Hayes. Andover: Elsevier Inc., October 2013, Food and Chemical Toxicology, Vol. 60, pp. 360-368. DOI: 10.1016/j.fct.2013.07.063; ISSN: 0278-6915.
  84. An approved preparation of Silybum marianum contains constituents with activity against Plasmodium falciparum. Montesino, N. Llurba, et al., et al. [ed.] Veronika Butterweck. S01, Muttenz: Georg Thieme Verlag KG, December 14, 2016, Planta Medica, Vol. 82, pp. S1-S381. DOI:; . ISSN: 0032-0943.
  85. The treatment of melasma by silymarin cream. Altaei, Tagreed. [ed.] Ioannis D. Bassukas, Feroze Kaliyadan and Xianyong Yin. 18, Ioannina; Hofuf; Chapel Hill: BioMed Central Ltd., October 2, 2012, BMC Dermatology, Vol. 12. DOI: 10.1186/1471-5945-12-18; eISSN: 1471-5945.
  86. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: Randomized, controlled, double-blind pilot study. Rotem, Carmela and Kaplan, Boris. [ed.] Andrea R. Genazzani. 2, Pisa: Informa Plc: International Society of Gynecological Endocrinology, March 2007, Gynecological Endocrinology, Vol. 23, pp. 117-122. DOI: 10.1080/09513590701200900; ISSN: 0951-3590.
  87. In-vitro and In-vivo Evaluation of Silymarin Nanoliposomes against Isolated Methicillin-resistant Staphylococcus aureus. Faezizadeh, Zohreh, Gharib, Amir and Godarzeeb, Masoud. [ed.] Nima Naderi. 2, Tehran: School of Pharmacy, Shahid Beheshti University of Medical Sciences, Spring 2015, Iranian Journal of Pharmaceutical Research, Vol. 14, pp. 627-633. PMCID: PMC4403081. ISSN: 1735-0328.
  88. Manganese Induces Oxidative Stress, Redox State Unbalance and Disrupts Membrane Bound ATPases on Murine Neuroblastoma Cells In Vitro: Protective Role of Silymarin. Chtourou, Yassine, et al., et al. [ed.] Abel Lajtha. 8, New York: Springer US, August 2011, Neurochemical Research, Vol. 36, pp. 1546-1557. DOI: 10.1007/s11064-011-0483-5; ISSN: 0364-3190.
  89. Improvement of Cerebellum Redox States and Cholinergic Functions Contribute to the Beneficial Effects of Silymarin Against Manganese-Induced Neurotoxicity. Chtourou, Yassine, et al., et al. [ed.] Arne Schousboe. 3, Copenhagen: Springer US, March 2012, Neurochemical Research, Vol. 37, pp. 469-479. DOI: 10.1007/s11064-011-0632-x; ISSN: 0364-3190.
  90. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive−Compulsive Disorder. Sayyah, Mehdi, et al., et al. [ed.] Guy Drolet. 2, Quebec: Elsevier Inc., March 17, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 34, pp. 362-365. DOI: 10.1016/j.pnpbp.2009.12.016; ISSN: 0278-5846.
  91. Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Elyasi, Sepideh, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 11, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., November 2016, Phytotherapy Research, Vol. 30, pp. 1879-1885. DOI: 10.1002/ptr.5704; eISSN: 1099-1573.
  92. Antiosteoclastic Activity of Milk Thistle Extract after Ovariectomy to Suppress Estrogen Deficiency-Induced Osteoporosis. Kim, Jung-Lye, et al., et al. [ed.] Gary S. Stein. Article ID 919374, s.l.: Hindawi Publishing Corporation, April 30, 2013, BioMed Research International, Vol. 2013, pp. 1-11. DOI: 10.1155/2013/919374; ISSN: 1110-7243.
  93. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Pérez-H, Jesús, et al., et al. [ed.] H.W.J. Marquardt and K.B. Wallace. Shannon: Elsevier Ireland Ltd., May 7, 2014, Toxicology, Vol. 319, pp. 38-43. DOI: 10.1016/j.tox.2014.02.009; ISSN: 0300-483X.
  94. Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer. Ting, Harold, Deep, Gagan and Agarwal, Rajesh. [ed.] Ho-Leung Fung. 3, Buffalo: Springer US: The American Association of Pharmaceutical Scientists, July 2013, The AAPS Journal, Vol. 15, pp. 707-716. DOI: 10.1208/s12248-013-9486-2; ISSN: 1550-7416.
  95. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Dehmlow, Carola, Murawski, Niels and de Groot, Herbert. 18, s.l.: Elsevier Inc., March 29, 1996, Life Sciences, Vol. 58, pp. 1591-1600. DOI: 10.1016/0024-3205(96)00134-8; ISSN: 0024-3205.
  96. Effect of supplement containing Silybum marianum extract, soy extract, collagen peptide, bifidobacteria and apple extract on skin: A randomized placebo-controlled, double-blind, parallel group comparative clinical study.. Ishii, Yuri, et al., et al. [ed.] Yoshikazu Yonei. 3, Kyoto: Society for Glycative Stress Research, September 30, 2016, Glycative Stress Research, Vol. 3, pp. 156-171. ISSN: 2188-3602.
  97. Silymarin, the antioxidant component of Silybum marianum, protects against burn-induced oxidative skin injury. Toklu, Hale Z., et al., et al. [ed.] S. Wolf. 7, San Antonio: Elsevier Ltd.; ISBI, November 2007, Burns, Vol. 33, pp. 908-916. DOI: 10.1016/j.burns.2006.10.407; ISSN: 0305-4179.
  98. Protective Effects of Silymarin Against Photocarcinogenesis in a Mouse Skin Model. Katiyar, Santosh K., et al., et al. [ed.] Barnett S. Kramer. 8, Rockville: Oxford University Press, April 16, 1997, Journal of the National Cancer Institute, Vol. 89, pp. 556-565. DOI: 10.1093/jnci/89.8.556; ISSN: 0027-8874.
  99. Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation. Tsai, May-Jywan, et al., et al. [ed.] E. Sylvester Vizi and Roger F. Butterworth. 8, Budapest; Montréal: Elsevier Ltd., December 2010, Neurochemistry International, Vol. 57, pp. 867-875. DOI: 10.1016/j.neuint.2010.09.005; ISSN: 0197-0186.
  100. Mechanisms involved in the gastro-protective effect of STW 5 (Iberogast®) and its components against ulcers and rebound acidity. Khayyal, M.T., et al., et al. [ed.] Hildebert Wagner, Norman R. Farnsworth and Yoshinori Asakawa. 1, München; Chicago; Tokushima: Elsevier GmbH: Urban and Fischer, November 24, 2006, Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, Vol. 13, pp. 56-66. DOI: 10.1016/j.phymed.2006.03.019; ISSN: 0944-7113.
  101. Gastric anti-ulcer activity of silymarin, a lipoxygenase inhibitor, in rats. Lastra, C. Alarcon De La, Martin, M.J. and Marhuenda, E. [ed.] David Jones. 11, Belfast: John Wiley & Sons, Inc., November 1992, Journal of Pharmacy and Pharmacology, Vol. 44, pp. 929-931. DOI: 10.1111/j.2042-7158.1992.tb03239.x; eISSN: 2042-7158.
  102. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation. Hou, Yu-Chang, et al., et al. [ed.] Hildebert Wagner. 12, München: Elsevier GmbH: Urban and Fischer, October 2010, Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, Vol. 17, pp. 963-973. DOI: 10.1016/j.phymed.2010.03.012; ISSN: 0944-7113.
  103. Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from β-thalassemia major patients. Alidoost, Fariba, et al., et al. [ed.] J.E. Talmadge and T.E. Hugli. 8, Omaha; San Diego: Elsevier B.V., August 2006, International Immunopharmacology, Vol. 6, pp. 1350-1310. DOI: 10.1016/j.intimp.2006.04.004; ISSN: 1567-5769.
  104. Effect of Silymarin and Harpagoside on Inflammation Reaction of BEAS-2B Cells, on Ciliary Beat Frequency (CBF) of Trachea Explants and on Mucociliary Clearance (MCC). Boeckenholt, Corinna, Begrow, Frank and Verspohl, Eugen J. [ed.] Luc Pieters. 8, Antwerp: Georg Thieme Verlag KG, March 12, 2012, Planta Medica, Vol. 78, pp. 761-766. DOI: 10.1055/s-0031-1298374; ISSN: 0032-0943.
  105. Effect of Topical Application of Silymarin (Silybum marianum) on Excision Wound Healing in Albino Rats. Sharifi, Roya, et al., et al. [ed.] Ahmadreza Dehpour. 9, Tehran: Tehran University of Medical Sciences, August 4, 2012, Acta Medica Iranica, Vol. 50, pp. 583-588. ISSN: 0044-6025.
  106. Obesity, Inflammation, and the Potential Application of Pharmaconutrition. Cave, Matt C., et al., et al. [ed.] Jeanette Hasse. 1, Dallas: SAGE Publications: American Society for Parenteral and Enteral Nutrition, February 2008, Nutrition in Clinical Practice, Vol. 23, pp. 16-34. DOI: 10.1177/011542650802300116; ISSN: 0884-5336.
  107. Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes. Bouderba, Saida, et al., et al. [ed.] Zachary T. Bloomgarden and Guang Ning. 2, New York City; Shanghai: Ruijin Hospital, Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd, March 2014, Journal of Diabetes, Vol. 6, pp. 184-192. DOI: 10.1111/1753-0407.12083; eISSN: 1753-0407.
  108. In vitro inhibitory potential of Cynara scolymus, Silybum marianum, Taraxacum officinale, and Peumus boldus on key enzymes relevant to metabolic syndrome. Villigera, Angela, et al., et al. [ed.] Hildebert Wagner. 1, Vallberga: Elsevier GmbH: Urban and Fischer, January 15, 2015, Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, Vol. 22, pp. 138-144. DOI: 10.1016/j.phymed.2014.11.015; ISSN: 0944-7113.
  109. Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. Derosa, Giuseppe, et al., et al. [ed.] Steve E. Humphries. 1, London: Elsevier Inc., March 1, 2015, Atherosclerosis, Vol. 239, pp. 87-92. DOI: 10.1016/j.atherosclerosis.2014.12.043; ISSN: 0021-9150.
  110. Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia. Pierro, Francesco Di, et al., et al. [ed.] Arthur E. Frankel. 9, Dallas: Dove Press Ltd, December 21, 2016, Clinical Pharmacology: Advances and Applications, Vol. 2017, pp. 1-7. ISSN: 1179-1438.
  111. Silibinin potentially protects arsenic-induced oxidative hepatic dysfunction in rats. Muthumani, M. and Prabuà, S. Milton. [ed.] Rakesh Dixit. 4, Gaithersburg: Taylor & Francis Group: Informa UK Limited, January 9, 2012, Toxicology Mechanisms and Methods, Vol. 22, pp. 277-288. DOI: 10.3109/15376516.2011.647113; ISSN: 1537-6516.
  112. Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damage. Parveen, Rabea, et al., et al. [ed.] Sang-Geon Kim. 5, Seoul: Pharmaceutical Society of Korea, May 2011, Archives of Pharmacal Research, Vol. 34, pp. 767-774. DOI: 10.1007/s12272-011-0510-8; ISSN: 0253-6269.
  113. Evaluation of the Protective Effect of Silibinin Against Diazinon Induced Hepatotoxicity and Free-Radical Damage in Rat Liver. Beydilli, Halil, et al., et al. [ed.] Seyed Amir Mohsen Ziaee. 4, Tehran: Kowsar Publishing Corporation, April 25, 2015, Iranian Red Crescent Medical Journal, Vol. 17, p. e25310. DOI: 10.5812/ircmj.17(4)2015.25310; ISSN: 2074-1804.
  114. Amelioration of lead toxicity on rat liver with Vitamin C and silymarin supplements. Shalan, M.G., et al., et al. [ed.] K.B. Wallace and H.W.J. Marquardt. 1, Duluth; Hamburg: Elsevier Ireland Ltd., January 5, 2005, Toxicology, Vol. 206, pp. 1-15. DOI: 10.1016/j.tox.2004.07.006; ISSN: 0300-483X.
  115. Protective Effect of Silymarin on Mercury-Induced Acute Nephro-Hepatotoxicity in Rats. Oda, Samah S. and El-Ashmawy, Ibrahim M. [ed.] Wahid Mohamed Ahmed. 4, Cairo: IDOSI Publications, 2012, Global Veterinaria, Vol. 9, pp. 376-383. ISSN: 1992-6197.
  116. Antioxidant activity of silybin in vivo during long-term iron overload in rats. Pietrangelo, Antonello, et al., et al. 6, s.l.: Elsevier B.V., December 1995, Gastroenterology, Vol. 109, pp. 1941-1949. DOI: 10.1016/0016-5085(95)90762-9; ISSN: 0016-5085.
  117. Bodemer, Apple A. Psoriasis. [ed.] David Rakel. Integrative Medicine. 3rd. Philadelphia: Saunders: Elsevier Inc., 2012, 69, pp. 645-656.e.2. ISBN: 978-1-4377-1793-8.
  118. The effect of silymarin on plasma levels of malon-dialdehyde in patients receiving long-term treatment with psychotropic drugs. Palasciano, Giuseppe, et al., et al. [ed.] Charles R. Ream. 5, Washington: Elsevier B.V., May 1994, Current Therapeutic Research, Vol. 55, pp. 537-545. DOI: 10.1016/S0011-393X(05)80184-5; ISSN: 0011-393X.
  119. Hepatoprotective Effect of Silymarin (Silybum marianum) on Hepatotoxicity Induced by Acetaminophen in Spontaneously Hypertensive Rats. Freitag, Abel Felipe, et al., et al. [ed.] Mohamed Eddouks. Article ID 538317, Meknes: Hindawi Publishing Corporation, January 21, 2015, Evidence-Based Complementary and Alternative Medicine, Vol. 2015, pp. 1-8. DOI: 10.1155/2015/538317; ISSN: 1741-427X.
  120. Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning. Mengs, Ulrich, Pohl, Ralf -Torsten and Mitchell, Todd. [ed.] Zeno Foldes-Papp. 10, Koeln-Wipperfuerth: Bentham Science Publishers, August 2012, Current Pharmaceutical Biotechnology, Vol. 13, pp. 1964-1970. DOI: 10.2174/138920112802273353; ISSN: 1389-2010.
  121. Effects of Echinacea purpurea on Hepatic and Renal Toxicity Induced by Diethylnitrosamine in Rats. Rezaie, Annahita, et al., et al. [ed.] Heibatullah Kalantari. 2, Ahvaz: School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Spring 2013, Jundishapur Journal of Natural Pharmaceutical Products, Vol. 8, pp. 60-64. PMCID: PMC3941908. ISSN: 1735-7780.
  122. Effect of silymarin on biliary bile salt secretion in the rat. Crocenzi, Fernando A., et al., et al. [ed.] Sam J. Enna. 8, Kansas City: Elsevier B.V., April 15, 2000, Biochemical Pharmacology, Vol. 59, pp. 1015-1022. DOI: 10.1016/S0006-2952(99)00407-4; ISSN: 0006-2952.
  123. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial. Loguercio, Carmela, et al., et al. [ed.] Kelvin J.A. Davies. 9, Los Angeles: Elsevier Inc., May 1, 2012, Free Radical Biology and Medicine, Vol. 52, pp. 1658-1665. DOI: 10.1016/j.freeradbiomed.2012.02.008; ISSN: 0891-5849.
  124. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen α1(I) and TIMP-1. Jia, Ji-Dong, et al., et al. [ed.] Juan Rodés. 3, Barcelona: Elsevier Inc.: European Association for the Study of the Liver, September 2001, Journal of Hepatology, Vol. 35, pp. 392-398. DOI: 10.1016/S0168-8278(01)00148-9; ISSN: 0168-8278.
  125. Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Škottová, Nina, et al., et al. [ed.] Emilio Clementi. 1, Milan: Elsevier Ltd., January 2003, Pharmacological Research, Vol. 47, pp. 17-26. DOI: 10.1016/S1043-6618(02)00252-9; ISSN: 1043-6618.
  126. Silymarin Inhibits In Vitro T-Cell Proliferation and Cytokine Production in Hepatitis C Virus Infection. Morishima, Chihiro, et al., et al. [ed.] Jr. Richard M. Peek. 2, Nashville: Elsevier B.V., February 2010, Gastroenterology, Vol. 138, pp. 671-681.e2. DOI: 10.1053/j.gastro.2009.09.021; ISSN: 0016-5085.
  127. Protection against liver ischemia-reperfusion injury in rats by silymarin or verapamil. Oliveira, C.P.M.S., et al., et al. [ed.] Felix T. Rapaport. 6, Stony Brook: Elsevier Inc., September 2001, Transplantation Proceedings, Vol. 33, pp. 3010-3014. DOI: 10.1016/S0041-1345(01)02288-6; ISSN: 0041-1345.
  128. Silymarin Accelerates Liver Regeneration after Partial Hepatectomy. Wu, Jia-Ping, et al., et al. [ed.] Ravirajsinh N. Jadeja. Article ID 603529, Augusta: Hindawi Publishing Corporation, January 22, 2015, Evidence-Based Complementary and Alternative Medicine, Vol. 2015, pp. 1-14. DOI: 10.1155/2015/603529; ISSN: 1741-427X.
  129. Radioprotective effect of silymarin against radiation induced hepatotoxicity. Ramadan, Laila A., et al., et al. [ed.] Emilio Clementi. 6, Milan: Elsevier Ltd., June 2002, Pharmacological Research, Vol. 46, pp. 447-454. DOI: 10.1006/phrs.2002.0990; ISSN: 1043-6618.
  130. A review of the bioavailability and clinical efficacy of milk thistle Phytosome: a silybin-phosphatidylcholine complex (Siliphos[R]). Kidd, Parris and Head, Kathleen. [ed.] Kathleen A. Head. 3, Napa: Thorne Research, Inc., September 1, 2005, Alternative Medicine Review, Vol. 10, pp. 193-203. PMID: 16164374. ISSN: 1089-5159.
  131. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. El-Kamary, Samer S., et al., et al. [ed.] Hildebert Wagner. 5, München: Elsevier GmbH: Urban and Fischer, May 2009, Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, Vol. 16, pp. 391-400. DOI: 10.1016/S0168-8278(98)80285-7; ISSN: 0944-7113.
  132. Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Seeff, Leonard B., et al., et al. [ed.] Keith D. Lindor. 2, Rochester: John Wiley & Sons, Inc.: American Association for the Study of Liver Diseases, February 2008, Hepatology, Vol. 47, pp. 605-612. DOI: 10.1002/hep.22044; eISSN: 1527-3350.
  133. Effects of silymarin supplementation in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study. Pár, Alajos, et al., et al. 2, Budapest: Akadémiai Kiadó, January 2009, Orvosi Hetilap, Vol. 150, pp. 73-79. DOI: 10.1556/OH.2009.28517; ISSN: 0030-6002.
  134. Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy: A Randomized Controlled Trial. Fried, Michael W., et al., et al. [ed.] Rita F. Redberg. 3, San Francisco: American Medical Association, July 18, 2012, JAMA, Vol. 303, pp. 274-282. DOI: 10.1001/jama.2012.8265; ISSN: 2168-6106.
  135. Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy. Ferenci, Peter, et al., et al. [ed.] Anil K. Rustgi. 5, Philadelphia: Elsevier B.V., November 2008, Gastroenterology, Vol. 135, pp. 1561-1567. DOI: 10.1053/j.gastro.2008.07.072; ISSN: 0016-5085.
  136. Rapid Suppression of Hepatitis C Viremia Induced by Intravenous Silibinin Plus Ribavirin. Biermer, Michael and Berg, Thomas. [ed.] Anil K. Rustgi. 1, Philadelphia: Elsevier B.V., July 2009, Gastroenterology, Vol. 137, pp. 390-391. DOI: 10.1053/j.gastro.2009.02.087; ISSN: 0016-5085.
  137. Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy. Neumann, U.P., et al., et al. [ed.] Didier Samuel. 6, Villejuif: Elsevier Inc.: European Association for the Study of the Liver, June 2010, Journal of Hepatology, Vol. 52, pp. 951-952. DOI: 10.1016/j.jhep.2010.02.002; ISSN: 0168-8278.
  138. A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients. Braun, Dominique L., et al., et al. [ed.] Sarah L. George. 7, St. Louis: Public Library of Science, July 15, 2015, PLoS ONE, Vol. 10, p. e0133028. DOI: 10.1371/journal.pone.0133028; eISSN: 1932-6203.
  139. Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period. Bárcena, Rafael, et al., et al. [ed.] Didier Samuel. 3, Villejuif: Elsevier Inc.: European Association for the Study of the Liver, March 2013, Journal of Hepatology, Vol. 58, pp. 421-426. DOI: 10.1016/j.jhep.2012.10.009; ISSN: 0168-8278.
  140. Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period. Mariño, Zoe, et al., et al. [ed.] Didier Samuel. 3, Villejuif: Elsevier Inc.: European Association for the Study of the Liver, March 2013, Journal of Hepatology, Vol. 58, pp. 415-420. DOI: 10.1016/j.jhep.2012.09.034; ISSN: 0168-8278.
  141. Silybin Treatment is Associated With Reduction in Serum Ferritin in Patients With Chronic Hepatitis C. Bares, Julie M., et al., et al. [ed.] Martin Floch. 8, New Haven: Lippincott Williams & Wilkins, Inc., September 2008, Journal of Clinical Gastroenterology, Vol. 42, pp. 937-944. DOI: 10.1097/MCG.0b013e31815cff36;;issue=09000&article=00013&type=abstract. ISSN: 0192-0790.
  142. Clinical Significance of Hepatic Iron Deposition and Serum. Iron Values in Patients with Chronic Hepatitis C Infection. Metwally, Mohamed A., Zein, Claudia O. and Zein, Nizar N. [ed.] Joel E. Richter and Nicholas J. Talley. 2, Tampa; Jacksonville: Nature Publishing Group: American College of Gastroenterology, February 2004, The American Journal of Gastroenterology, Vol. 99, pp. 286-291. DOI: 10.1111/j.1572-0241.2004.04049.x; ISSN: 0002-9270.
  143. Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B. Wei, F., et al., et al. [ed.] Alex Van Belkum. 5, La Balme les Grottes: Springer-Verlag, May 2013, European Journal of Clinical Microbiology & Infectious Diseases, Vol. 32, pp. 657-669. DOI: 10.1007/s10096-012-1789-1; ISSN: 0934-9723.
  144. A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. Luangchosiri, Chote, et al., et al. [ed.] Thomas A. Rowles. 334, London: BioMed Central Ltd., September 23, 2015, BMC Complementary and Alternative Medicine, Vol. 15. DOI: 10.1186/s12906-015-0861-7; ISSN: 1472-6882.
  145. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. Parés, Albert, et al., et al. [ed.] Gustav Paumgartner. 4, Munich: Elsevier Inc.: European Association for the Study of the Liver, April 1998, Journal of Hepatology, Vol. 28, pp. 615-621. DOI: 10.1016/S0168-8278(98)80285-7; ISSN: 0168-8278.
  146. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Patel, Nirav, et al., et al. [ed.] Michael P. Waalkes. 2, Research Triangle Park: Elsevier B.V., June 1, 2010, Toxicology and Applied Pharmacology, Vol. 245, pp. 143-1552. DOI: 10.1016/j.taap.2010.02.002; ISSN: 0041-008X.
  147. Preventive and protective effects of silymarin on doxorubicin-induced testicular damages correlate with changes in c-myc gene expression. Malekinejad, H., et al., et al. [ed.] Hildebert Wagner. 12, München: Elsevier GmbH: Urban and Fischer, September 15, 2012, Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, Vol. 19, pp. 1077-1084. DOI: 10.1016/j.phymed.2012.06.011; ISSN: 0944-7113.
  148. Phytochemicals as Cell Cycle Modulators: A Less Toxic Approach in Halting Human Cancers. Singh, Rana P., Dhanalakshmi, Sivanandhan and Agarwal, Rajesh. [ed.] Mikhail V. Blagosklonny. 3, Buffalo: Landes Bioscience, May/June 2002, Cell Cycle, Vol. 1, pp. 156-161. DOI: 10.4161/cc.1.3.117; ISSN: 1538-4101.
  149. Kouris-Blazos, Antigone. Drug-nutrient-herb interactions for commonly prescribed medications. [ed.] Vicki Kotsirilos. A Guide to Evidence-Based Integrative and Complementary Medicine. Chatswood: Churchill Livingstone: Elsevier Australia, 2011, Appendix 2, pp. 901-922. ISBN: 978-0-7295-3908-1.
  150. Silibinin Sensitizes Human Glioma Cells to TRAIL-Mediated Apoptosis via DR5 Up-regulation and Down-regulation of c-FLIP and Survivin. Son, Yong-gyu, et al., et al. [ed.] Frank J. Rauscher III. 17, Philadelphia: American Association for Cancer Research, September 1, 2007, Cancer Research, Vol. 67, pp. 8274-8284. DOI: 10.1158/0008-5472.CAN-07-0407; ISSN: 0008-5472.
  151. Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin. Bhatia, Neehar, et al., et al. [ed.] Manfred Schwab. 1-2, Heidelberg: Elsevier Ireland Ltd., December 1, 1999, Cancer Letters, Vol. 147, pp. 77-84. DOI: 10.1016/S0304-3835(99)00276-1; ISSN: 0304-3835.
  152. Curcumin and Silibinin Inhibit Telomerase Expression in T47D Human Breast Cancer Cells. Nasiri, Marzieh, et al., et al. [ed.] Malcolm A. Moore. 6, Goyang-si Gyeonggi-do: Asian Pacific Organization for Cancer Prevention, 2013, Asian Pacific Journal of Cancer Prevention , Vol. 14, pp. 3449-3453. DOI: 10.7314/APJCP.2013.14.6.3449; ISSN: 1513-7368.
  153. Therapeutic Effect of Silybum marianum Plant Extract on Tamoxifen-Induced Fatty Liver in Rats. Behrouj, Hamid, et al., et al. [ed.] Mohammad Taghi Goodarzi. 1, Hamadan: Kowsar Medical, March 1, 2015, Avicenna Journal of Medical Biochemistry, Vol. 3, p. e27160 . DOI: 10.17795/ajmb-27160; ISSN: 2345-4113.
  154. Flavonoid, Silibinin, Inhibits Proliferation and Promotes Cell-Cycle Arrest of Human Colon Cancer. Hogan, Fawn S., et al., et al. [ed.] David W. McFadden and Wiley W. Souba. 1, Burlington; Columbus: Elsevier B.V., November 2007, Journal of Surgical Research, Vol. 143, pp. 58-65. DOI: 10.1016/j.jss.2007.03.080; ISSN: 0022-4804.
  155. Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells. Eo, Hyun Ji, et al., et al. [ed.] J.E. Talmadge. 1, Omaha: Elsevier B.V., January 2015, International Immunopharmacology, Vol. 24, pp. 1-6. DOI: 10.1016/j.intimp.2014.11.009; ISSN: 1567-5769.
  156. Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells. Tsai, Cheng-Chia, et al., et al. [ed.] Damian Garcia-Olmo, et al., et al. 14, Madrid; Orlando; Stockholm; Long Beach: Baishideng Publishing Group Co., Limited, April 14, 2015, World Journal of Gastroenterology, Vol. 21, pp. 4169-4177. DOI: 10.3748/WJG.v21.i14.4169; ISSN: 1007-9327.
  157. Curcumin Sensitizes Silymarin to Exert Synergistic Anticancer Activity in Colon Cancer Cells. Montgomery, Amanda, et al., et al. [ed.] Yan-Gao Man and Naoto T. Ueno. 10, Baltimore; Houston: Ivyspring International Publisher, June 23, 2016, Journal of Cancer, Vol. 7, pp. 1250-1257. DOI: 10.7150/jca.15690; ISSN: 1837-9664.
  158. Pilot Study of Oral Silibinin, a Putative Chemopreventive Agent, in Colorectal Cancer Patients: Silibinin Levels in Plasma, Colorectum, and Liver and Their Pharmacodynamic Consequences. Hoh, Carmen, et al., et al. [ed.] William Neil Hait. 9, Boston: American Association for Cancer Research, May 1, 2006, Clinical Cancer Research, Vol. 12, pp. 2944-2950. DOI: ISSN: 1078-0432.
  159. Autophagy Induction by Silibinin Positively Contributes to Its Anti-Metastatic Capacity via AMPK/mTOR Pathway in Renal Cell Carcinoma. Li, Feng, et al., et al. [ed.] Mark L. Richter. 4, Lawrence: MDPI AG, April 2015, International Journal of Molecular Sciences, Vol. 16, pp. 8415-8429. DOI: 10.3390/ijms16048415; eISSN: 1422-0067.
  160. Effects of silymarin on the spontaneous proliferation and cell cycle of human peripheral blood leukemia T cells. Gharagozloo, Marjan and Amirghofran, Zahra. [ed.] Klaus Höffken. 8, Düsseldorf: Springer Berlin Heidelberg, August 2007, Journal of Cancer Research and Clinical Oncology, Vol. 133, pp. 525-532. DOI: 10.1007/s00432-007-0197-x; ISSN: 0171-5216.
  161. Significantly greater antioxidant anticancer activities of 2,3-dehydrosilybin than silybin. Huber, Axel, et al., et al. [ed.] C.G. Gahmberg and S.S. Krag. 5, Helsinki; Baltimore: Elsevier B.V., May 2008, Biochimica et Biophysica Acta (BBA) - General Subjects, Vol. 1780, pp. 837-847. DOI: 10.1016/j.bbagen.2007.12.012; ISSN: 0304-4165.
  162. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells. Gu, Ha Ra, et al., et al. [ed.] Yoon Jun Kim. 1, Seoul: Korean Association for the Study of the Liver, March 25, 2015, Clinical and Molecular Hepatology, Vol. 21, pp. 49-59. DOI: 10.3350/cmh.2015.21.1.49; ISSN: 2287-2728.
  163. Silibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stress. Kalemci, Serdar, et al., et al. [ed.] Demetrios A. Spandidos. 2, Athens: Spandidos Publications, August 2015, Experimental and Therapeutic Medicine, Vol. 10, pp. 503-507. DOI: 10.3892/etm.2015.2542; ISSN: 1792-0981.
  164. Antioxidant effect of silymarin on paraquat-induced human lung adenocarcinoma A549 cell line. Podder, Biswajit, et al., et al. [ed.] A. Wallace Hayes. 9, Andover: Elsevier Inc., September 2012, Food and Chemical Toxicology, Vol. 50, pp. 3206-3214. DOI: 10.1016/j.fct.2012.06.007; ISSN: 0278-6915.
  165. Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2. Hsieh, Yih-Shou, et al., et al. [ed.] Curtis C. Harris. 5, Bethesda: Oxford University Press, November 20, 2007, Carcinogenesis, Vol. 28, pp. 977-987. DOI: 10.1093/carcin/bgl221; ISSN: 0143-3334.
  166. Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells. Fan, Li, et al., et al. [ed.] F.P. Nijkamp and W.H. Gispen. Utrecht: Elsevier B.V., November 15, 2014, European Journal of Pharmacology, Vol. 743, pp. 79-88. DOI: 10.1016/j.ejphar.2014.09.019; ISSN: 0014-2999.
  167. Dietary Feeding of Silibinin Inhibits Advance Human Prostate Carcinoma Growth in Athymic Nude Mice and Increases Plasma Insulin-like Growth Factor-binding Protein-3 Levels. Singh, Rana P., et al., et al. [ed.] Frank J. Rauscher III. 11, Philadelphia: American Association for Cancer Research, June 2002, Cancer Research, Vol. 62, pp. 3063-3069. ISSN: 0008-5472.
  168. Skin Cancer Chemopreventive Effects of a Flavonoid Antioxidant Silymarin Are Mediated via Impairment of Receptor Tyrosine Kinase Signaling and Perturbation in Cell Cycle Progression. Ahmad, Nihal, et al., et al. [ed.] William J. Lennarz. 2, Baltimore: Academic Press, June 18, 1998, Biochemical and Biophysical Research Communications, Vol. 247, pp. 294-301. DOI: 10.1006/bbrc.1998.8748; ISSN: 0006-291X.
  169. A Flavonoid Antioxidant, Silymarin, Affords Exceptionally High Protection against Tumor Promotion in the SENCAR Mouse Skin Tumorigenesis Model. Lahiri-Chatterjee, Moushumi, et al., et al. [ed.] Frank J. Rauscher III. 3, Philadelphia: American Association for Cancer Research, February 1, 1999, Cancer Research, Vol. 59, pp. 622-632. ISSN: 0008-5472.
  170. Attenuation of UVA-induced damage to human keratinocytes by silymarin. Svobodová, Alena, et al., et al. [ed.] Hiroshi Shimizu. 1, Sapporo: Elsevier Inc., April 2007, Journal of Dermatological Science, Vol. 46, pp. 21-30. DOI: 10.1016/j.jdermsci.2006.12.009; ISSN: 0923-1811.
  171. Dietary Feeding of Silibinin Prevents Early Biomarkers of UVB Radiation-Induced Carcinogenesis in SKH-1 Hairless Mouse Epidermis. Gu, Mallikarjuna, et al., et al. [ed.] David S. Alberts and John D. Potter. 5, Tuscon; Seattle: American Association for Cancer Research, May 2005, Cancer Epidemiology, Biomarkers & Prevention, Vol. 14, pp. 1344-1349. DOI: 10.1158/1055-9965.EPI-04-0664; ISSN: 1055-9965.
  172. Silibinin Inhibits Inflammatory and Angiogenic Attributes in Photocarcinogenesis in SKH-1 Hairless Mice. Gu, Mallikarjuna, et al., et al. [ed.] Frank J. Rauscher III. 7, Philadelphia: American Association for Cancer Research, April 1, 2007, Cancer Research, Vol. 67, pp. 3483-3491. DOI: 10.1158/0008-5472.CAN-06-3955; ISSN: 0008-5472.
  173. Effect of Silymarin in the Prevention of Cisplatin Nephrotoxicity, a Clinical Trial Study. Momeni, Ali, et al., et al. [ed.] Hemant Jain. 4, Delhi: JCDR Research and Publications (P) Limited, April 2015, Journal of Clinical and Diagnostic Research, Vol. 9, pp. 11-13. DOI: 10.7860/JCDR/2015/12776.5789; ISSN: 2249-782X.
  174. A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Ladas, Elena J., et al., et al. [ed.] Raphael E. Pollock. 2, Houston: John Wiley & Sons, Inc., January 15, 2010, Cancer, Vol. 116, pp. 506-513. DOI: 10.1002/cncr.24723; eISSN: 1097-0142.
  175. Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemia. McBride, Ali, et al., et al. [ed.] Barry R. Goldspiel. 3, Bethesda: SAGE Publications Ltd., February 29, 2012, Journal of Oncology Pharmacy Practice, Vol. 18, pp. 1-6. DOI: 10.1177/1078155212438252; ISSN: 1078-1552.
  176. Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin. Bosch-Barrera, Joaquim, et al., et al. [ed.] Andrei V. Gudkov and Mikhail V. Blagosklonny. 22, Buffalo: Impact Journals, LLC, May 31, 2016, Oncotarget, Vol. 7, pp. 32006-32014. DOI: 10.18632/oncotarget.7900; eISSN: 1949-2553.
  177. Silibinin Administration Improves Hepatic Failure Due to Extensive Liver Infiltration in a Breast Cancer Patient. Bosch-Barrera, Joaquim, et al., et al. [ed.] John G. Delinasios. 8, Highlands: The International Institute of Anticancer Research, August 2014, Anticancer Research, Vol. 34, pp. 4323-4327. ISSN: 0250-7005.
  178. A presurgical study of oral silybin-phosphatidylcholine in patients with early breast cancer. Lazzeroni, Matteo, et al., et al. [ed.] Scott M. Lippman. 1, Philadelphia: American Association for Cancer Research, January 2016, Cancer Prevention Research, Vol. 9, pp. 89-95. DOI: 10.1158/1940-6207.CAPR-15-0123; ISSN: 1940-6207.
  179. Effects of A Breast-Health Herbal Formula Supplement on Estrogen Metabolism in Pre- and Post-Menopausal Women not Taking Hormonal Contraceptives or Supplements: A Randomized Controlled Trial. Laidlaw, Maggie, Cockerline, Carla A and Sepkovic, Daniel W. [ed.] Goberdhan P. Dimri. Washington, DC: Libertas Academica, December 16, 2010, Breast Cancer: Basic and Clinical Research, Vol. 4, pp. 85-95. DOI: 10.4137/BCBCR.S6505; ISSN: 1178-2234.
  180. The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy-a six month placebo-controlled double-blind clinical trial. Vidlar, Ales, et al., et al. [ed.] Jitka Ulrichová and Vilím Šimánek. 3, Olomouc: Palacký University, Faculty of Medicine and Dentistry, September 1, 2010, Biomedical Papers, Vol. 154, pp. 239-244. DOI: 10.5507/bp.2010.036; ISSN: 1213-8118.
  181. Randomized, Double-Blind, Placebo-Controlled Crossover Study in Men with Prostate Cancer and Rising PSA: Effectiveness of a Dietary Supplement. Schröder, Fritz H., et al., et al. [ed.] C.C. Schulman. 6, Brussels: Elsevier B.V., December 2005, European Urology, Vol. 48, pp. 922-931. DOI: 10.1016/j.eururo.2005.08.005; ISSN: 0302-2838.
  182. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Soto, Claudia, et al., et al. [ed.] Thomas P. Mommsen and Patrick J. Walsh. 3, Victoria; Miami: Elsevier Inc., November 2003, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, Vol. 136, pp. 205-212. DOI: 10.1016/S1532-0456(03)00214-X; ISSN: 1532-0456.
  183. Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model. Soto, C., et al., et al. [ed.] Hildebert Wagner. 3, Vallberga: Elsevier GmbH: Urban and Fischer, February 15, 2014, Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, Vol. 21, pp. 233-239. DOI: 10.1016/j.phymed.2013.09.008; ISSN: 0944-7113.
  184. Investigation of α-Amylase and α-Glucosidases Inhibitory Effects of Silybum marianum (L. Gaertn) Seed Extracts In Vitro. Huseini, H. Fallah, et al., et al. [ed.] Sh. Akhoundzadeh. 41, S8, Tehran: Iranian Academic Center of Education, Culture and Research, November 22, 2014, Journal of Medicinal Plants, Vol. 1, pp. 239-247. ISSN: 1684-0240.
  185. Study of the hypoglycaemic activity of Fraxinus excelsior and Silybum marianum in an animal model of type 1 diabetes mellitus. Maghrani, M., et al., et al. [ed.] Robert Verpoorte. 2-3, Leiden: Elsevier Ireland Ltd., April 2004, Journal of Ethnopharmacology, Vol. 91, pp. 309-316. DOI: 10.1016/j.jep.2004.01.008; ISSN: 0378-8741.
  186. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: A randomized, triple-blind, placebo-controlled clinical trial. Koujan, Soraiya Ebrahimpour, et al., et al. [ed.] Alexander Panossian. 2, Vallberga: Elsevier GmbH: Urban and Fischer, February 15, 2015, Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, Vol. 22, pp. 290-296. DOI: 10.1016/j.phymed.2014.12.010; ISSN: 0944-7113.
  187. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Huseini, H. Fallah, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 12, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., December 2006, Phytotherapy Research, Vol. 20, pp. 1036-1039. DOI: 10.1002/ptr.1988; eISSN: 1099-1573.
  188. Effect of silymarin on biochemical parameters of oxidative stress in aged and young rat brain. Galhardi, F., et al., et al. [ed.] Joseph F. Borzelleca and Alan R. Boobis. 10, Richmond; London: Elsevier Ltd., October 2009, Food and Chemical Toxicology, Vol. 47, pp. 2655-2660. DOI: 10.1016/j.fct.2009.07.030; ISSN: 0278-6915.
  189. Evaluation of the Neuroprotective Effect of Silymarin on Acrylamide-Induced Neurotoxicity. Mehri, Soghra, et al., et al. [ed.] Heibatullah Kalantari. 4, Ahvaz: Kowsar Medical, December 2016, Jundishapur Journal of Natural Pharmaceutical Products, Vol. 11, p. e37644. DOI: 10.17795/jjnpp-37644; ISSN: 1735-7780.
  190. Flavonoids as Natural Stabilizers and Color Indicators of Ageing for Polymeric Materials. Masek, Anna. [ed.] Alexander Böker. 6, Potsdam-Golm: MDPI AG, June 18, 2015, Polymers, Vol. 7, pp. 1125-1144. DOI: 10.3390/polym7061125; eISSN: 2073-4360.
  191. Anti-Aging Effects of Some Selected Iranian Folk Medicinal Herbs-Biochemical Evidences. Mohammadirad, Azadeh, et al., et al. [ed.] Fazly Bazzaz and BiBi Sedigheh. 11, Mashhad: Mashhad University of Medical Sciences, November 2013, Iranian Journal of Basic Medical Sciences, Vol. 16, pp. 1170-1180. PMCID: PMC3909629. ISSN: 2008-3866.
  192. Topical Application of Silybum Marianum Extract. Fehér, Pálma, et al., et al. [ed.] Liana Moş. 2, Arad: Vasile Goldis University Press, 2011, Arad Medical Journal, Vol. XIV, pp. 5-8. ISSN: 2067-7790.
  193. Protective effect of silymarin on oxidative stress in rat brain. Nencini, C., Giorgi, G. and Micheli, L. [ed.] Hildebert Wagner, Norman R. Farnsworth and Yoshinori Asakawa. 2-3, München; Chicago; Tokushima: Elsevier GmbH: Urban and Fischer, February 19, 2007, Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, Vol. 14, pp. 129-135. DOI: 10.1016/j.phymed.2006.02.005; ISSN: 0944-7113.
  194. Silymarin effect on amyloid-β plaque accumulation and gene expression of APP in an Alzheimer's disease rat model. Yaghmaei, Parichehreh, et al., et al. [ed.] Mohammad Abdollahi. 24, Tehran: BioMed Central Ltd., January 24, 2014, DARU Journal of Pharmaceutical Sciences, Vol. 22. DOI: 10.1186/2008-2231-22-24; ISSN: 2008-2231.
  195. Silymarin Attenuated the Amyloid β Plaque Burden and Improved Behavioral Abnormalities in an Alzheimer's Disease Mouse Model. Murata, Nakaba, et al., et al. [ed.] Kazumitsu Ueda. 11, Kyoto: Japan Society for Bioscience, Biotechnology, and Agrochemistry, November 23, 2010, Bioscience, Biotechnology, and Biochemistry, Vol. 74, pp. 2299-2309. DOI: 10.1271/bbb.100524; ISSN: 0916-8451.
  196. Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment. Tota, Santoshkumar, et al., et al. [ed.] Joe P. Huston and Stephen Maren. 1, Düsseldorf; College Station: Elsevier B.V., August 1, 2011, Behavioural Brain Research, Vol. 221, pp. 207-215. DOI: 10.1016/j.bbr.2011.02.041; ISSN: 0166-4328.
  197. Silymarin Extends Lifespan and Reduces Proteotoxicity in C. elegans Alzheimer's Model. Kumar, Jitendra, et al., et al. [ed.] Stephen D. Skaper. 2, Padova: Bentham Science Publishers, March 1, 2015, CNS & Neurological Disorders - Drug Targets, Vol. 14, pp. 295-302. DOI: 10.2174/1871527314666150116110212; ISSN: 1871-5273.
  198. Association between sepsis and dementia. Kao, Li-Ting, et al., et al. [ed.] Charles Liu. 9, Los Angeles: Elsevier Ltd., September 2015, Journal of Clinical Neuroscience, Vol. 22, pp. 1430-1433. DOI: 10.1016/j.jocn.2015.02.035; ISSN: 0967-5868.
  199. Silybin, a new iron-chelating agent. Borsari, Marco, et al., et al. [ed.] J.H. Dawson. 2-3, Columbia: Elsevier Science B.V., June 2001, Journal of Inorganic Biochemistry, Vol. 85, pp. 123-129. DOI: 10.1016/S0162-0134(01)00198-2; ISSN: 0162-0134.
  200. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. Kell, Douglas B. [ed.] Tim Sands. 2, London: BioMed Central Ltd., January 8, 2009, BMC Medical Genomics, Vol. 2. DOI: 10.1186/1755-8794-2-2; ISSN: 1755-8794.
  201. Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats. Haddadi, Rasool, et al., et al. [ed.] Hadi Valizadeh. 4, Tabriz: Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, November 2015, Advanced Pharmaceutical Bulletin, Vol. 5, pp. 463-469. DOI: 10.15171/apb.2015.063; ISSN: 2228-5881.
  202. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: Involvement of estrogen receptors and oxidative stress. Baluchnejadmojarad, Tourandokht, Roghani, Mehrdad and Mafakheri, Mehdi. [ed.] Stephen G. Waxman. 3, New Haven: Elsevier Ireland Ltd., August 23, 2010, Neuroscience Letters, Vol. 480, pp. 206-210. DOI: 10.1016/j.neulet.2010.06.038; ISSN: 0304-3940.
  203. Amelioration of cognitive, motor and endogenous defense functions with silymarin, piracetam and protocatechuic acid in the cerebral global ischemic rat model. Muley, Milind M., et al., et al. [ed.] Loren E. Wold. 1, Columbus: Elsevier Inc., July 19, 2013, Life Sciences, Vol. 93, pp. 51-57. DOI: 10.1016/j.lfs.2013.05.020; ISSN: 0024-3205.
  204. Neurotrophic and neuroprotective effects of milk thistle (Silybum marianum) on neurons in culture. Kittur, Smita, et al., et al. [ed.] Illana Gozes. 3, Tel Aviv: Humana Press Inc, June 2002, Journal of Molecular Neuroscience, Vol. 18, pp. 265-269. DOI: 10.1385/JMN:18:3:265; ISSN: 0895-8696.
  205. Anti-Glycation Activities of Phenolic Constituents from Silybum marianum. Shin, Seoungwoo, et al., et al. [ed.] Derek J. McPhee. 3, Emeryville: MDPI AG, February 19, 2015, Molecules, Vol. 20, pp. 3549-3564. DOI: 10.3390/molecules20033549; ISSN: 1420-3049.
  206. Relevance of the mouse skin initiation-promotion model for the classification of carcinogenic substances encountered at the workplace. Schwarz, Michael, et al., et al. [ed.] Gio B. Gori. 1, Bethesda: Elsevier Inc., June 2015, Regulatory Toxicology and Pharmacology, Vol. 72, pp. 150-157. DOI: 10.1016/j.yrtph.2015.03.014; ISSN: 0273-2300.
  207. Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin. Zhao, Jifu, et al., et al. [ed.] Curtis C. Harris. 4, Bethesda: Oxford University Press, April 1, 2000, Carcinogenesis, Vol. 21, pp. 811-816. DOI: 10.1093/carcin/21.4.811; ISSN: 0143-3334.
  208. Modulation of Cox-1, 5-, 12- and 15-Lox by Popular Herbal Remedies Used in Southern Italy Against Psoriasis and Other Skin Diseases. Bader, Ammar, et al., et al. [ed.] Elizabeth M. Williamson, et al., et al. 1, Reading; Naples; Seoul; Charleston: John Wiley & Sons, Ltd., January 2015, Phytotherapy Research, Vol. 29, pp. 108-113. DOI: 10.1002/ptr.5234; eISSN: 1099-1573.
  209. Instrumental evaluation of anti aging effects of cosmetic formulations containing palmitoyl peptides, Silybum marianum seed oil, vitamin E and other functional ingredients on aged human skin. Hahn, Hyung Jin, et al., et al. [ed.] Demetrios A. Spandidos. 2, Athens: Spandidos Publications, August 2016, Experimental and Therapeutic Medicine, Vol. 12. DOI: 10.3892/etm.2016.3447; ISSN: 1792-0981.
  210. Nutrition and Health of Dogs and Cats: Evolution of Petfood. Bontempo, Valentino. [ed.] Robert G. Dalziel. Supplement 2, Edinburgh: Springer Science + Business Media, Inc., August 2005, Veterinary Research Communications, Vol. 29, pp. 45-50. DOI: 10.1007/s11259-005-0010-8; ISSN: 0165-7380.
  211. Evaluation of silymarin in the treatment on asymptomatic Giardia infections in dogs. Chon, Seung-Ki and Kim, Nam-Soo. [ed.] H. Mehlhorn and B. Chobotar. 6, Düsseldorf; Berrien Springs: Springer-Verlag, December 2005, Parasitology Research, Vol. 97, pp. 445-451. DOI: 10.1007/s00436-005-1462-z; ISSN: 0932-0113.
  212. Encounters with fierce dogs and itchy bedbugs: why my first field work failed. Svanberg, Ingvar. [ed.] Andrea Pieroni. 39, Bra: BioMed Central Ltd., May 2, 2014, Journal of Ethnobiology and Ethnomedicine, Vol. 10. DOI: 10.1186/1746-4269-10-39; ISSN: 1746-4269.
  213. Prospective Randomized Clinical Trial Assessing the Efficacy of Denamarin for Prevention of CCNU-Induced Hepatopathy in Tumor-Bearing Dogs. Skorupski, K.A., et al., et al. [ed.] Stephen P. DiBartola and Kenneth W. Hinchcliff. 4, Columbus; Melbourne: John Wiley & Sons, Inc., July/August 2011, Journal of Veterinary Internal Medicine, Vol. 25, pp. 838-845. DOI: 10.1111/j.1939-1676.2011.0743.x; ISSN: 0891-6640.
  214. Evaluation of prophylactic and therapeutic effects of silymarin on mebendazole-induced hepatotoxicity in cats. Mosallanejad, Bahman, et al., et al. [ed.] Paul Sibbons. 5, Harrow: Springer-Verlag, October 2012, Comparative Clinical Pathology, Vol. 21, pp. 681-685. DOI: 10.1007/s00580-010-1157-4; ISSN: 1618-5641.
  215. Evaluation of prophylactic and therapeutic effects of silymarin on acute toxicity due to tetracycline severe overdose in cats: a preliminary study. Mosallanejad, B., et al., et al. [ed.] A. Khodakaram-Tafti. 1, Shiraz: School of Veterinary Medicine of Shiraz University, January 2012, Iranian Journal of Veterinary Research, Vol. 13, pp. 16-22. ISSN: 2252-0589.
  216. Evaluation of prophylactic and therapeutic effects of silymarin and N-acetylcysteine in acetaminophen-induced hepatotoxicity in cats. Avizeh, R., et al., et al. [ed.] Jim E. Riviere, et al., et al. 1, Manhattan; Hannover; Queensland: John Wiley & Sons Ltd., February 2010, Journal of Veterinary Pharmacology and Therapeutics, Vol. 33, pp. 95-99. DOI: 10.1111/j.1365-2885.2009.01100.x; eISSN: 1365-2885.
  217. Supplements for Exotic Pets. Mejia-Fava, Johanna and Colitz, Carmen M.H. [ed.] Jörg Mayer. 3, Athens: Elsevier Inc., September 2014, Veterinary Clinics of North America: Exotic Animal Practice, Vol. 17, pp. 503-525. DOI: 10.1016/j.cvex.2014.05.001; ISSN: 1094-9194.
  218. Land-use changes and monk parakeet expansion in the Pampas grasslands of Argentina. Bucher, Enrique H. and Aramburú, Rosana M. [ed.] Peter Linder. 6, Zurich: John Wiley & Sons Ltd., June 2014, Journal of Biogeography, Vol. 41, pp. 1160-1170. DOI: 10.1111/jbi.12282; eISSN: 1365-2699.
  219. Cultivation of Silybum marianum Gaertn., a promising medicinal plant. Kapahi, B.K., et al., et al. [ed.] P.R. Krishna Kumar. 4, Coimbatore: Medknow: The Ayurvedic Trust, April 1995, Ancient Science of Life, Vol. 14, pp. 240-244. ISSN: 0257-7941.
  220. Tamime, Adnan Y. Brined Cheeses. Oxford: Blackwell Publishing Ltd: John Wiley & Sons, 2006. ISBN: 978-1-4051-2460-7.
  221. Bailey, Steven and Trivieri, Larry. Juice Alive: The Ultimate Guide to Juicing Remedies. Garden City Park: Square One Publishers, Inc., 2007. ISBN: 978-0-7570-0266-3.
  222. Bobrow, Warren. Apothecary Cocktails: Restorative Drinks from Yesterday and Today. Beverly: Quaryside Publishing Group: Fair Winds Press, 2013. ISBN: 978-1-61058-859-1.
  223. Stevens, Becca. The Way of Tea and Justice: Rescuing the World's Favorite Beverage from Its Violent History. New York: Hachette Book Group: Jericho Books, 2014. ISBN: 978-1-4555-1903-3.
  224. Jessica K. Black, N.D. The Anti-Inflammation Diet and Recipe Book: Protect Yourself and Your Family from Heart Disease, Arthritis, Diabetes, Allergies - And More. First. Alameda: Hunter House Inc., Publishers, 2006. ISBN: 978-089793-485-5.
  225. Runyon, Linda. The Essential Wild Food Survival Guide. Shiloh: Wild Food Company, 2007. ISBN: 0-936699-10-8.
  226. Ballerini, Luigi. A Feast of Weeds: A Literary Guide to Foraging and Cooking Wild Edible Plants. Berkeley; Los Angeles: University of California Press, 2012. ISBN: 978-0-520-27034-3.
  227. Masé, Guido and King, Jovial. DIY Bitters: Reviving the Forgotten Flavor - A Guide to Making Your Own Bitters for Bartenders, Cocktail Enthusiasts, Herbalists, and More. Beverly: Quarto Publishing Group USA Inc.: Fair Winds Press, 2016. ISBN: 978-1-59233-704-0.
  228. Folk pharmaceutical knowledge in the territory of the Dolomiti Lucane, inland southern Italy. Pieroni, Andrea, Quave, Cassandra L. and Santoro, Rocco Franco. [ed.] Robert Verpoorte. 2-3, Leiden: Elsevier Ireland Ltd., December 2004, Journal of Ethnopharmacology, Vol. 95, pp. 373-384. DOI: 10.1016/j.jep.2004.08.012; ISSN: 0378-8741.
  229. Sturtevant, Edward Lewis. Sturtevant's Notes on Edible Plants. [ed.] U.P. Hedrick. Albany: J.B. Lyon Company, State Printers, 1919. Vols. 2, Part II. State of New York - Department of Agriculture; 27th Annual Report.
  230. Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate-type allergy to kiwi fruit. Geier, J., Fuchs, T. and Wahl, R. [ed.] Karl Feistle. 10, Remscheid: München-Deisenhofen: Dustri-Verlag, 1990, Allergologie, Vol. 13, pp. 387-388. CABI Record Number: 19911439429 . ISSN: 0344-5062.
  231. The Ethno Botanical Uses of Medicinal Plants of Allai Valley, Western Himalaya Pakistan. Haq, Faizul. [ed.] Krystyna Skalicka-Woźniak. 1, Lublin: Scientific & Academic Publishing, 2012, International Journal of Plant Research, Vol. 2, pp. 21-34. DOI: 10.5923/j.plant.20120201.04; ISSN: 2163-2596.
  232. Allen and Ticknor. The Toilette of Health, Beauty, and Fashion: Embracing the Economy of the Beard, Breath, Complexion, Ears, Eyes, Eye-brows, Eye Lashes, Feet, Forehead, Gums, Hair, Head, Hands, Lips, Mouth, Mustachios, Nails of the Toes, Nails of the Fingers, Nose, Skin, Teeth, Tongue, Etc., Etc., : Including the Comforts of Dress and the Decorations of the Neck ... with Directions for the Use of Most Safe and Salutary Cosmetics ... and a Variety of Selected Recipes for the Dressing Room of Both Sexes. Boston: s.n., 1833.
  233. Chase, Alvin Wood. Dr. Chase's Third, Last and Complete Receipt Book and Household Physician, Or, Practical Knowledge for the People: From the Life-long Observations of the Author, Embracing the Choicest, Most Valuable and Entirely New Receipts in Every Department of Medicine, Mechanics, and Household Economy : Including a Treatise on the Diseases of Women and Children, in Fact, the Book for the Million, with Remarks and Explanations which Adapt it to the Every-day Wants of the People, Arranged in Departments and Most Copiously Indexed. 3rd. Detroit; Ontario: s.n., 1893.
  234. Soir, A.B. Du. Ancient Methods of Vermin Killing. [ed.] Percy Lund. The Naturalist's World. London: W. Swan Sonnenchein & Co., 1884, p. 113.
Disclaimer: This website is not intended to replace professional consultation, diagnosis, or treatment by a licensed physician. If you require any medical related advice, contact your physician promptly. Information presented on this website is exclusively of a general reference nature. Do not disregard medical advice or delay treatment as a result of accessing information at this site.